NDC 72482-100
Vonjo
Pacritinib
Vonjo is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Cti Biopharma Corp.. The primary component is Pacritinib.
| Product ID | 72482-100_8dbc8c92-e63c-43cf-8584-333d8b53ddde |
| NDC | 72482-100 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Vonjo |
| Generic Name | Pacritinib |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2022-02-28 |
| Marketing Category | NDA / |
| Application Number | NDA208712 |
| Labeler Name | CTI BioPharma Corp. |
| Substance Name | PACRITINIB |
| Active Ingredient Strength | 100 mg/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
Packaging
NDC 72482-100-12
40 CARTON in 1 BOX (72482-100-12) > 1 BOTTLE in 1 CARTON > 120 CAPSULE in 1 BOTTLE
| Marketing Start Date | 2022-02-28 |
| NDC Exclude Flag | N |
| Sample Package? | N |
Drug Details
Trademark Results [Vonjo]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 VONJO 90480655 not registered Live/Pending |
CTI Biopharma Corp. 2021-01-21 |
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.